Australia markets close in 3 hours 39 minutes
  • ALL ORDS

    7,347.60
    +21.40 (+0.29%)
     
  • ASX 200

    7,110.00
    +17.00 (+0.24%)
     
  • AUD/USD

    0.7003
    +0.0027 (+0.39%)
     
  • OIL

    113.90
    -0.30 (-0.26%)
     
  • GOLD

    1,824.50
    +10.50 (+0.58%)
     
  • BTC-AUD

    42,746.65
    -1,095.35 (-2.50%)
     
  • CMC Crypto 200

    670.74
    +428.06 (+176.39%)
     
  • AUD/EUR

    0.6702
    +0.0022 (+0.33%)
     
  • AUD/NZD

    1.1079
    +0.0034 (+0.30%)
     
  • NZX 50

    11,115.59
    -42.07 (-0.38%)
     
  • NASDAQ

    12,243.58
    -143.82 (-1.16%)
     
  • FTSE

    7,464.80
    +46.65 (+0.63%)
     
  • Dow Jones

    32,223.42
    +26.76 (+0.08%)
     
  • DAX

    13,964.38
    -63.55 (-0.45%)
     
  • Hang Seng

    20,290.03
    +339.82 (+1.70%)
     
  • NIKKEI 225

    26,648.55
    +101.50 (+0.38%)
     

Progyny, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 A.M. Eastern Time. Following the presentation, Michael Sturmer, Progyny’s President, and Mark Livingston, Progyny’s Chief Financial Officer, will join Mr. Anevski for a breakout session.

A live audiocast and replay of both the presentation and the breakout session will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting